FdaApplication
ANDA 204144
Identifiers
- fda_app_no: ANDA204144
Properties
| Property | Value |
|---|---|
| applicant_name | PH HEALTH LTD |
| application_type | ANDA |
| approval_date | 2025-06-04 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 500MG;EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 1GM;EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| SITAGLIPTIN AND METFORMIN HYDROCHLORIDE | METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE | 1GM;EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
3 products